General Information


DRACP ID  DRACP03521

Peptide Name  

Sequence  FW

Sequence Length  2

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03521

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  3MeACl

C-terminal Modification  TDA

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C20H21N3O3

Absent amino acids  ACDEGHIKLMNPQRSTVY

Common amino acids  FW

Mass  36942

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  2

Net charge  0

Boman Index  531

Hydrophobicity  95

Aliphatic Index  0

Half Life 
  Mammalian: >20 hour
  Yeast: >20 hour
  E.coli: ?

Extinction Coefficient cystines  5500

Absorbance 280nm  5500

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 19081951

Title  Antimicrobial activity, biocompatibility and hydrogelation ability of dipeptide-based amphiphiles

Doi Not available

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  6162

DRACP is developed by Dr.Zheng's team.